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Background: The optimal indication for side branch (SB) ballooning and/or stenting is unknown.
Methods: The present trial was a prospective, randomized, open-label, single-center trial comparing the 2 strategies (conservative versus 
aggressive) for SB intervention during coronary bifurcation stenting. A total of 258 patients with a coronary bifurcation lesion (SB diameter 2.3mm) 
treated with drug-eluting stent (DES) were randomized either to conservative or aggressive strategy for SB ballooning and/or stenting. Main vessel 
(MV) stenting was performed in both groups. In the conservative group, SB ballooning was done if TIMI flow<3 after MV stenting in non-left main 
bifurcation (non-LM), and diameter stenosis (DS) >75% in left main bifurcation (LM). SB stenting was performed if TIMI flow <3 SB after ballooning 
in non-LM, and DS >50% or dissection after ballooning in LM. In the aggressive group, SB ballooning was done if DS >75% after MV stenting in non-
LM, and DS >50% in LM. SB stenting was performed if DS >50% after ballooning in non-LM, and DS >30% or dissection after ballooning in LM. The 
primary end point was target vessel failure (TVF): cardiac death, myocardial infarction, or target vessel revascularization for 9 months.
Results: LM bifurcation lesion was noted in 114 patients (44%) and true bifurcation lesion in 171 patients (66%). SB dilation after MV stenting 
was more frequently required in the aggressive group than in the conservative group (70.0% versus 25.0%, P<0.001). SB stenting after SB dilation 
was more frequently required in the aggressive group than in the conservative group (30.0% versus 7.8%, P<0.001). The aggressive group was 
associated with a significantly higher incidence of periprocedural myocardial infarction compared to the conservative group (16.2% versus 7.8%, 
P=0.04). At 9 months, the incidence of TVF was similar in the 2 groups (7.7% in the aggressive group versus 8.6% in the conservative group, P=0.79).
Conclusion: The conservative strategy for SB ballooning and/or stenting was not associated with increased incidence of clinical events compared 
to the aggressive strategy in patients undergoing coronary bifurcation stenting with DES.
